Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
15.67
+0.18 (1.16%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.28 billion as of April 25, 2025. Its market cap has decreased by -17.83% in one year.
Market Cap
2.28B
Enterprise Value
1.14B
1-Year Change
-17.83%
Ranking
Category
Stock Price
$15.67
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.28B, an increase of 20.58%. That is a compound annual growth rate of 2.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.16B |
| UnitedHealth Group | 387.92B |
| Johnson & Johnson | 372.76B |
| AbbVie | 317.18B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.77B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |